Kadimastem Ltd
TLV: KDST.TA0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Tel Aviv Stock Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Ronen Twito CPA
- Employees
- 11
- Headquarters
- Ness Ziona, Israel
- IPO year
- 2013
- Market cap
- ILA 125.7M
- Website
- https://www.kadimastem.com
Loading KDST…
Loading profile data…Frequently asked questions about KDST
What does Kadimastem Ltd (KDST.TA) do?
Kadimastem Ltd, a biopharmaceutical company, develops regenerative medicine therapies based on cells derived from human embryonic stem cells to treat neuro-degenerative diseases. Its products in pipeline include AstroRx, a clinical grade human astrocytes that is in Phase 1/2a clinical trial for the treatment of amyotrophic lateral sclerosis and...
Where does KDST.TA trade?
Kadimastem Ltd (KDST.TA) trades on the Tel Aviv Stock Exchange.
What sector is KDST.TA in?
Kadimastem Ltd (KDST.TA) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Kadimastem Ltd?
Ronen Twito CPA is the chief executive officer of Kadimastem Ltd (KDST.TA).
Where is Kadimastem Ltd headquartered?
Kadimastem Ltd is headquartered in Israel.
Does KDST.TA pay a dividend?
Kadimastem Ltd (KDST.TA) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did KDST.TA go public?
Kadimastem Ltd (KDST.TA) completed its initial public offering in 2013.